Additional file 2 of Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway

Additional file 2: Table S1. Clinical properties of the ovarian cancer patients used in the analysis. Table S2. Summary of the sequences of ZIP13 sgRNAs and primers for CRISPR. Table S3. Primers used in quantitative real-time RT-PCR. Table S4. The association of ZIP transporters with overall survival (OS) and progression-free survival (PFS) in patients with serous ovarian cancer. Table S5. Correlation of ZIP13 gene expression with survival in different clinical stages in ovarian cancer patients. Table S6. Correlation of ZIP13 gene expression with survival in different pathological grades in ovarian cancer patients. Table S7. KEGG pathway enrichment analysis of the ZIP13-regulated genes. Table S8. GO analysis of the biological processes associated with ZIP13-regulated genes. Table S9. GO analysis of the molecular functions associated with ZIP13-regulated genes. Table S10. KEGG pathway enrichment analysis of the ZIP13-regulated genes in ovarian cancer patients from TCGA.